查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1863247

按成像方式、组件、最终用户、应用和技术类型分類的诊断成像市场—2025-2032年全球预测

Diagnostic Imaging Market by Modality, Component, End User, Application, Technology Type - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，诊断影像市场将成长至 435.3 亿美元，复合年增长率为 5.63%。

关键市场统计数据
基准年 2024 280.7亿美元
预计年份：2025年 296.5亿美元
预测年份 2032 435.3亿美元
复合年增长率 (%) 5.63%

权威深入剖析不断发展的诊断影像生态系统，重点关注临床优先事项、技术融合和采购现状，以支持明智的决策。

随着技术、监管和组织等多面向因素的融合，诊断影像领域正经历加速变革时期。医疗服务提供者和技术供应商都面临着提高临床诊疗量、提升诊断准确性以及在整个医疗服务链中展现价值的压力。同时，硬体小型化、高阶软体分析和云端工作流程等方面的创新正在重塑成像服务的交付和使用方式。

本执行摘要旨在为领导者提供指导，帮助他们应对影响临床影像专案和供应商策略的结构性变革。它整合了对负责资本规划、临床整合和供应商选择的决策者至关重要的几个关键主题。本摘要力求提供一份简洁明了、以证据为基础的入门指南，不预设一成不变的解决方案，而是着重强调风险、策略槓桿作用和近期营运重点。

读者将看到一篇平衡的论述，它将特定模式的进步与软体、服务和监管路径方面的更广泛趋势联繫起来。该论文重点阐述了对采购週期、临床应用和组织准备的实际影响，并概述了建议的战略应对措施，这些措施能够在保持临床品质的同时实现成本效益高的现代化。透过将策略选择建立在营运现实之上，这篇导言为更深入地探讨转型、政策影响、细分市场细微差别、区域趋势和建议行动奠定了基础。

对人工智慧、模组化硬体、资料互通性和监管奖励如何重塑诊断成像服务和供应商策略进行清晰分析

诊断影像领域正经历变革性的转变，重新定义了资本密集型设备与软体主导的临床支援之间的平衡。先进的分析技术和人工智慧模型正从概念验证阶段走向常规临床支持，在许多机构中广泛应用，加速了工作流程自动化、影像重建、重要发现优先排序和处方笺报告的生成。这些能力的提升，重新激发了人们对软体优先策略和厂商合作的兴趣，将装置效能与云端原生分析结合。

同时，硬体发展正着重于便携性、低场磁振造影系统、模组化电脑断层扫描平台以及可实现分散式诊断的照护现场超音波阵列。这些硬体发展趋势，加上检测器灵敏度和影像处理的进步（可降低辐射暴露并提高患者舒适度），正在影响临床通讯协定和应用模式。随着影像平台越来越支持治疗性介入、影像导引介入和混合手术室工作流程，影像方式与介入手术的融合正在加速。

在营运层面，互通性和资料管治正成为核心要务。医疗机构正在寻求能够与电子健康记录和临床决策支援系统集成，同时又能保障网路安全和病患隐私的系统。供应商则透过联邦学习方法、加密资料交换和更紧密的整合框架来应对这项需求。最后，监管路径和基于价值的报销模式正在推动患者疗效和诊疗效率的显着提升，使采购决策从纯粹的技术规格转向可验证的临床和经济价值。

2025 年关税环境如何重塑诊断影像生态系统的采购趋势、供应商策略和供应链韧性

2025年实施的关税和贸易措施给诊断影像设备及其组件的整个供应链和采购管道带来了巨大压力。关税上调及相关的合规要求延长了前置作业时间，尤其是那些从地理位置集中的供应商采购的关键组件和子系统。医疗服务提供者和供应商被迫调整价格、重新谈判供应商合约并重新评估库存策略，以维持服务的连续性并确保用于患者照护的资金投入。

关税的实际影响体现在终端设备定价和零件层面的经济效益两方面，促使製造商评估替代采购管道，尽可能实现生产地域多角化，并加快设计变更以减少对受关税影响零件的依赖。这种累积效应挤压了部分供应商的利润空间，同时也刺激了他们加强对供应链韧性的投入。医疗机构的采购週期也随之延长，因为采购团队将关税条款和紧急时应对计画纳入招标书，而资本委员会则仔细权衡采购时机和潜在的成本波动。

除了采购之外，关税环境也影响了策略伙伴的选择和创新蓝图。拥有多元化製造地和强大服务网路的供应商更有能力承担额外成本并保持准时交货。同时，规模较小的供应商面临更大的压力，需要调整价格并转向服务导向模式。总体而言，2025年的关税环境凸显了供应链实质审查、灵活的合约结构以及强调透明度和风险共担的合作型供应商关係的战略重要性。

这种细緻入微、细分化的观点，着重展现了驱动临床应用和采购选择的各种模式、组件、最终用户、应用和技术类型的动态变化。

深入的市场区隔揭示了临床需求与技术能力相契合的领域，以及投资能带来最大营运效率的领域。从影像方式的差异来看，电脑断层扫描（CT）可分为锥状射束CT、常规CT和可携式CT，每种CT在门诊、急诊和术中诊断等不同场景下都具有不同的提案。磁振造影（MRI）包括高场、低场和超高场MRI，每种MRI在空间解析度、可及性和营运成本方面各有优劣。核子医学又分为正子断层扫描（PET）和单光子发射电脑断层扫描（SPECT）两个亚专科，它们分别驱动肿瘤学和心臟病学的通讯协定。同时，超音波技术涵盖了从二维到超音波、超音波超音波多普勒超音波的各个方面，涵盖了从床边分诊到高阶介入影像的广泛应用。 X射线仍然是一项基础技术，透过电脑放射成像和数数位放射线放射成像格式不断发展，朝着剂量效率和快速数位化工作流程的方向发展。

组件级细分着重于利润率、服务强度和升级週期。线圈、检测器、产生器和换能器等硬体元件决定了基准影像品质和整体拥有成本 (TCO)，而咨询、安装、维护和培训等服务则支援运作和临床医生的采用。由人工智慧分析、PACS、报告软体和RIS组成的软体套件是长期临床价值的差异化因素，并支援在分散式环境中扩展诊断功能。最终用户细分反映了采购行为和使用模式的多样性：诊所优先考虑吞吐量和经济性，诊断中心专注于吞吐量和特色服务，医院在模式广度和与复杂诊疗路径的整合之间取得平衡，而研究机构则重视实验室能力和对先进模式的支持。基于应用的细分揭示了在心臟病学、牙科、神经病学、妇产科、肿瘤学、眼科学和整形外科等领域，模式和软体投资如何产生临床影响。每个领域都有其自身的成像通讯协定和监管要求。最后，按技术类型对 2D、3D 和 4D 成像进行分割，建构了从平面诊断到体积和时间分析的演进过程，以帮助进行手术规划和长期监测。

综上所述，这些细分层次揭示了供应商和提供者的策略方向：模组化硬体投资应与每种终端使用者类型的关键临床应用场景相匹配；软体和服务应适应特定成像方式的工作流程；培训和维护服务应根据每种先进成像技术的技术复杂性进行扩展。将细分洞察融入采购流程和产品蓝图，将有助于实现针对性创新，从而满足不同实践环境和专科领域的独特临床价值。

对美洲、欧洲、中东和非洲以及亚太地区的采用模式、监管复杂性和采购行为进行区域战略分析

受报销模式、管理体制和製造地驱动的区域趋势，持续影响技术普及的停滞期和成长加速期。在美洲，对企业影像、人工智慧整合和基于价值的医疗倡议的投资主要集中在临床疗效和效率方面，这既支持大型医疗系统采用先进技术，也为社区医院和门诊中心创造了对中端设备的需求。公共和私人支付方的架构会影响采购时机和资金分配，进一步凸显了证明疗效和效率提升的证据的重要性。

监管协调和多样化的报销环境导致欧洲、中东和非洲地区（EMEA）呈现多元化的应用路径。西欧医疗中心倾向于领先早期临床应用和软体支援的工作流程整合，而许多中东市场则选择性地投资于三级医疗中心的高端设备。在非洲部分地区，医疗资源的限制和人才分布不均推动了对携带式、经济高效的影像解决方案的需求，以最大限度地扩大临床覆盖范围。能够根据当地资金筹措结构调整经营模式并优先考虑服务网络的供应商更有可能在这种多元化的环境中蓬勃发展。

在亚太地区，国内製造业能力、政府主导的医疗保健扩张以及快速的都市化相互作用，共同创造了一个两极化的市场。都市区的先进医疗中心正在部署尖端影像设备和混合介入手术室，而广大的农村和郊区则更需要扩充性、低成本的治疗方式和远端影像服务。区域供应链和本地零件製造能够降低关税风险，并加快客製化解决方案的上市速度。了解这些区域特征对于使产品策略、经销伙伴和临床教育计画与当地需求和营运实际情况相符至关重要。

对硬体现有企业、软体新兴企业和专业服务提供者的竞争策略、合作伙伴关係和能力投资进行评估性概述，这些策略、伙伴关係和能力投资使它们彼此区分开来。

诊断影像领域的竞争格局呈现出硬体厂商、快速成长的软体专家以及不断扩展的服务供应商生态系统并存的局面。现有设备製造商持续投资于平台现代化和现场服务拓展，以维护其现有用户群并增加服务主导收入。同时，软体主导的新兴参与企业和人工智慧专家在临床决策支援、影像增强和工作流程自动化领域逐渐占据主导，促使现有供应商透过合作、收购或自主研发分析技术来保持竞争力。

诊断影像设备製造商与云端服务供应商和分析公司之间的策略联盟正成为供应商寻求提供整合解决方案而非独立设备的趋势。这些合作优先考虑将奖励与基于订阅的软体和管理服务相结合的联合销售策略，从而围绕运转率、患者疗效和持续产品改进来製定激励机制。此外，那些建立了强大的培训和远端支援能力的公司，能够提高临床医生对产品的接受度，并降低设备生命週期内的总拥有成本，从而脱颖而出。

併购和定向投资持续重塑供应商格局，但差异化越来越依赖证明临床疗效、合规性和可扩展部署模式的能力。在现场服务、资料安全和互通性表现卓越的企业正成功地将先导计画发展成为企业级部署。专注于模组化、经济性和以用户为中心的设计的新兴参与企业在门诊中心和新兴市场找到了机会，而高级产品则集中在先进的急诊医院系统和研究机构。

切实可行的逐步策略，以增强供应链韧性，实现软体和服务的商业化，并使证据产生与支付方和监管机构的预期保持一致。

行业领导者应采取一系列切实可行的有序措施，以应对动盪局面并从持续的技术变革中获益。首先，应优先考虑供应链的韧性，具体措施包括：供应商多元化、寻找替代零件来源，以及实施能够应对贸易政策波动的灵活合约条款。这将有助于降低交货风险，并保障临床客户的业务连续性。

其次，它加速了软体整合和模组化设计，从而实现了增量升级和订阅收入。将硬体生命週期与软体创新分离的机构能够在不强制过早更换硬体的情况下，持续改善临床应用。第三，对服务和人才培养的投资：大规模部署、预防性保养和临床医生培训计划，能够提高产品采用率并维护品牌声誉。这些投资能够带来持续收入并加强客户关係。

第四，我们将透过支持真实世界证据研究、卫生经济学分析和互通性标准，使产品开发和证据生成与支付方和监管机构的期望保持一致。我们将透过展示诊断准确性、治疗时间和工作流程效率的可衡量改进，来降低采购和报销障碍。第五，我们将推动区域专业化策略：使定价、资金筹措和服务模式在地化，以反映区域支付结构和营运实际情况。最后，我们将推动永续性和生命週期规划，以降低能耗、延长设备使用寿命，并落实机构的ESG（环境、社会和管治）倡议。这些措施将共同建构一个兼顾创新和营运可靠性的稳健商业模式。

一种严谨、多方面的研究途径，结合了关键相关人员访谈、技术检验和情境分析，以产生可用于决策的洞见。

本研究采用综合分析调查方法，强调对关键相关人员的意见、技术文件和观察分析进行三角验证，以确保研究结果的稳健性和实用性。主要研究包括对临床负责人、采购负责人、现场工程师和技术主管进行结构化访谈，以收集有关特定模式性能、服务挑战和推广障碍的第一手资料。此外，还参考了技术白皮书、监管文件和产品文献，以检验设备的功能和合规进度。

分析方法采用跨模态类型、组件生命週期和软体生态系统的比较功能映射，以确保横断面分析的一致性。基于情境的评估分析了供应链中断、政策变化和技术采用对营运的影响，同时专家小组对综合结果进行验证，以最大限度地减少解释偏差。检验过程中的资料品管包括资讯来源三角验证、技术规范版本控制以及对定性断言的敏感性检查。

由于保密原因，我们无法取得专有销售数据和机构层面的采购合同，这构成了本研究的局限性；此外，区域差异也需要根据当地情况调整部分操作建议。然而，我们的调查方法强调透明度、可重复性和实际应用性，能够提供与当前临床实践和供应商策略直接相关的见解。

一份简洁的核心优先事项概要，整合了技术创新、临床表现和营运韧性，以确保诊断影像领域的长期价值。

诊断影像领域正处于一个转折点，技术创新、服务模式和政策环境在此交汇融合，重新定义临床影像的价值。如今在供应链结构、软体整合和服务能力方面做出的策略选择，将决定哪些机构能够获得临床价值并保持竞争优势。那些能够从系统观点出发，平衡硬体能力、软体驱动的工作流程、人员配备和资金筹措机制的相关人员，将更有能力将创新转化为日常临床效益。

最成功的路径将强调模组化、基于证据的价值提案以及能够抵御政策和供应衝击的弹性运作模式。透过互通性、临床医生采纳以及诊断结果和吞吐量的显着提升，医疗服务提供者和供应商可以协调整个医疗服务链中的奖励，并实现更可预测的采购週期。最终，该领域的近期重点是将试点规模的创新转化为扩充性、安全且以临床医生为中心的解决方案，从而支持患者就医和实现组织目标。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

  • 将人工智慧演算法整合到诊断成像工作流程中，以提高诊断准确性和效率。
  • 在偏远地区和流动医疗机构中，携带式和照护现场超音波设备在分散式成像方面的应用日益广泛。
  • 实施云端基础的PACS和影像共用平台，以促进远端放射学和协作诊断
  • 开发用于早期检测微血管和结构异常的超高解析度成像诊断方法
  • 透过在CT和X射线系统中引入辐射剂量降低技术来提高病患安全

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：以影像方式分類的诊断影像市场

  • 电脑断层扫描
    • 锥状射束CT
    • 常规电脑断层扫描
    • 可携式电脑断层扫描器
  • 磁振造影
    • 高场磁振造影
    • 低场磁振造影
    • 超高场磁振造影
  • 核子医学
    • 正子断层扫描
    • 单光子发射电脑断层扫描
  • 超音波
    • 二维超音波
    • 三维超音波
    • 4D超音波
    • 超音波
  • X射线
    • 电脑放射线摄影
    • 数位放射线摄影

9. 按组件分類的诊断影像市场

  • 硬体
    • 线圈
    • 检测器
    • 发电机
    • 感应器
  • 服务
    • 咨询
    • 安装
    • 维护
    • 训练
  • 软体
    • 人工智慧分析
    • PACS
    • 报表软体
    • RIS

第十章：按最终用户分類的诊断影像市场

  • 诊所
  • 诊断中心
  • 医院
  • 研究所

第十一章 按应用分類的诊断影像市场

  • 心臟病学
  • 牙科
  • 神经病学
  • 妇产科
  • 肿瘤学
  • 眼科
  • 整形外科

第十二章：按技术类型分類的诊断影像市场

  • 二维成像
  • 三维成像
  • 4D成像

第十三章：按地区分類的诊断影像市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章 按组别分類的诊断影像市场

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 各国诊断影像市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章 竞争格局

  • 2024年市占率分析
  • FPNV定位矩阵，2024
  • 竞争分析
    • GE HealthCare Technologies, Inc.
    • Siemens Healthineers AG
    • Koninklijke Philips NV
    • Canon Medical Systems Corporation
    • Fujifilm Holdings Corporation
    • Samsung Medison Co., Ltd.
    • Mindray Medical International Limited
    • Shimadzu Corporation
    • Hitachi, Ltd.
    • Hologic, Inc.
Product Code: MRR-CF6C60CF95AA

The Diagnostic Imaging Market is projected to grow by USD 43.53 billion at a CAGR of 5.63% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 28.07 billion
Estimated Year [2025] USD 29.65 billion
Forecast Year [2032] USD 43.53 billion
CAGR (%) 5.63%

An authoritative orientation to the evolving diagnostic imaging ecosystem highlighting clinical priorities, technology convergence, and procurement realities for informed decision-making

The diagnostic imaging landscape is in a period of accelerated transformation driven by converging technological, regulatory, and organizational forces. Healthcare providers and technology vendors alike face mounting pressure to improve clinical throughput, enhance diagnostic accuracy, and demonstrate value across episodes of care. At the same time, innovation in hardware miniaturization, advanced software analytics, and cloud-enabled workflows is reshaping how imaging services are delivered and consumed.

This executive summary orients leaders to the structural changes affecting clinical imaging programs and supplier strategies. It synthesizes cross-cutting themes that matter most to decision-makers responsible for capital planning, clinical integration, and vendor selection. The intent is to provide a concise, evidence-based primer that highlights risks, strategic levers, and near-term operational priorities without presuming a single one-size-fits-all solution.

Readers will find a balanced discussion that connects modality-specific advances to broader trends in software, services, and regulatory pathways. The narrative emphasizes practical implications for procurement cycles, clinical adoption, and organizational readiness, and outlines recommended strategic responses that preserve clinical quality while enabling cost-effective modernization. By grounding strategic choices in operational realities, the introduction sets the stage for deeper examination of shifts, policy impacts, segmentation nuances, regional dynamics, and recommended actions.

A clear-eyed analysis of how AI, modular hardware, data interoperability, and regulatory incentives are reshaping diagnostic imaging delivery and vendor strategies

Diagnostic imaging is undergoing transformative shifts that are redefining the balance between capital-intensive equipment and software-driven clinical augmentation. Advanced analytics and AI models have moved beyond proof-of-concept to routine clinical augmentation in many centers, accelerating workflow automation, image reconstruction, prioritization of critical findings, and prescriptive reporting. These capabilities are driving renewed interest in software-first strategies and vendor partnerships that blend device performance with cloud-native analytics.

Simultaneously, hardware evolution is focusing on portability, lower-field magnetic resonance systems, modular computed tomography platforms, and point-of-care ultrasound arrays that enable decentralized diagnostics. These hardware trends are complemented by improvements in detector sensitivity and image processing that reduce radiation exposure and improve patient comfort, thereby influencing clinical protocols and utilization patterns. Convergence between imaging modalities and interventional procedures is intensifying as imaging platforms increasingly support therapeutics, image-guided interventions, and hybrid operating room workflows.

Operationally, interoperability and data governance have emerged as central imperatives; institutions demand systems that integrate with electronic health records and clinical decision support while maintaining cybersecurity and patient privacy. Suppliers are responding with federated learning approaches, encrypted data exchange, and tighter integration frameworks. Finally, regulatory pathways and value-based reimbursement models are incentivizing quantifiable improvements in patient outcomes and throughput, shifting procurement decisions toward demonstrable clinical and economic value rather than purely technical specifications.

How the 2025 tariff environment has reshaped procurement dynamics, supplier strategies, and supply chain resilience across diagnostic imaging ecosystems

The introduction of tariffs and trade measures in 2025 imposed material pressures across supply chains and procurement pathways for diagnostic imaging equipment and components. Increased duties and related compliance requirements have amplified lead times for critical assemblies and subsystems, particularly those sourced from geographically concentrated suppliers. Providers and vendors have had to navigate price adjustments, renegotiate supplier contracts, and reassess inventory strategies to maintain service continuity and preserve capital allocation toward patient care.

In practical terms, tariffs affected both end-equipment pricing and component-level economics, prompting manufacturers to evaluate alternate sourcing, regionalize production where feasible, and accelerate design changes that reduce reliance on tariff-affected parts. The cumulative effect tightened margins for some suppliers while catalyzing investment in supply chain resilience. For healthcare organizations, procurement cycles lengthened as contract teams incorporated tariff clauses and contingency planning into RFPs, and capital committees weighed the timing of purchases against potential cost volatility.

Beyond procurement, the tariff environment influenced strategic partner selection and innovation roadmaps. Vendors with diversified manufacturing footprints and robust services networks were better positioned to absorb incremental costs and maintain delivery commitments. Meanwhile, smaller suppliers faced intensified pressure to reprice or pivot toward service-oriented models. Overall, the 2025 tariff landscape reinforced the strategic importance of supply chain due diligence, flexible contracting, and collaborative vendor relationships that prioritize transparency and shared risk mitigation.

A granular segmentation-based perspective revealing modality, component, end-user, application, and technology type dynamics that drive clinical adoption and procurement choices

Insightful segmentation reveals where clinical demand aligns with technological capability and where investment will unlock the greatest operational leverage. When examining modality distinctions, computed tomography spans cone beam computed tomography, conventional computed tomography, and portable computed tomography each with distinct value propositions in ambulatory, emergency, and intraoperative settings. Magnetic resonance imaging encompasses high-field magnetic resonance imaging, low-field magnetic resonance imaging, and ultra-high-field magnetic resonance imaging, with trade-offs among spatial resolution, accessibility, and cost to operate. Nuclear medicine divides into positron emission tomography and single photon emission computed tomography specialties that drive oncology and cardiology protocols, while ultrasound technologies-from 2D ultrasound to 3D ultrasound, 4D ultrasound, and Doppler ultrasound-serve a broad continuum from point-of-care triage to sophisticated interventional imaging. X-ray remains foundational through computed radiography and digital radiography formats that continue to evolve toward dose efficiency and rapid digital workflows.

Component-level segmentation frames where margins, service intensity, and upgrade cycles concentrate. Hardware elements such as coils, detectors, generators, and transducers determine baseline image quality and TCO, while services including consulting, installation, maintenance, and training underpin uptime and clinician adoption. Software suites composed of AI analytics, PACS, reporting software, and RIS increasingly act as differentiators for longitudinal clinical value, enabling diagnostics to scale across distributed settings. End-user segmentation captures heterogeneity in purchasing behavior and utilization patterns: clinics prioritize throughput and affordability, diagnostic centers focus on throughput and niche services, hospitals balance breadth of modalities with integration into complex care pathways, and research institutes emphasize experimental capability and advanced modality support. Application-based segmentation highlights where modality and software investments yield clinical impact across cardiology, dental, neurology, obstetrics and gynecology, oncology, ophthalmology, and orthopedics, each with unique imaging protocols and regulatory considerations. Finally, technology-type segmentation spanning 2D imaging, 3D imaging, and 4D imaging frames the progression from planar diagnostics to volumetric and temporal analyses that support procedural planning and longitudinal monitoring.

Taken together, these segmentation layers illuminate strategic vectors for suppliers and providers: modular hardware investments should align with the dominant clinical use cases of each end-user type, software and services must be tailored to modality-specific workflows, and training and maintenance offerings must scale to the technical complexity of advanced imaging types. Integrating segmentation intelligence into procurement and product roadmaps enables targeted innovation that addresses differential clinical value across settings and specialties.

A regional strategic breakdown of adoption patterns, regulatory complexity, and procurement behavior across the Americas, Europe Middle East & Africa, and Asia-Pacific landscapes

Regional dynamics continue to shape where adoption plateaus and where growth accelerates, driven by reimbursement models, regulatory regimes, and manufacturing footprints. In the Americas, investment in enterprise imaging, AI integration, and value-based care initiatives emphasizes clinical outcomes and efficiency, supporting uptake of advanced modalities in large health systems while also creating demand for mid-tier devices in community hospitals and outpatient centers. Public and private payer structures influence procurement timing and capital allocation, reinforcing the importance of evidence demonstrating improvements in outcomes and throughput.

Across Europe, Middle East & Africa, regulatory harmonization and diverse reimbursement environments create a mosaic of adoption trajectories. Western European centers often lead in early clinical adoption and integration of software-enabled workflows, while many markets in the Middle East invest selectively in high-end modalities for tertiary care hubs. In parts of Africa, capacity constraints and workforce distribution underscore demand for portable and cost-efficient imaging solutions that maximize clinical reach. Vendors that adapt commercial models to local financing structures and prioritize service networks often gain traction in these varied contexts.

In Asia-Pacific, the interplay of domestic manufacturing capabilities, government-led healthcare expansion, and rapid urbanization drives a dual market: sophisticated tertiary centers in urban hubs adopt cutting-edge imaging and hybrid interventional suites, while extensive rural and peri-urban populations create demand for scalable, lower-cost modalities and tele-imaging services. Regional supply chains and local component manufacturing can mitigate tariff exposure and accelerate time-to-market for tailored solutions. Understanding these regional contours is essential to align product strategies, distribution partnerships, and clinical education programs with regional demand and operational realities.

An evaluative overview of competitive strategies, partnerships, and capability investments that differentiate hardware incumbents, software challengers, and service-focused providers

Competitive dynamics in diagnostic imaging are characterized by a blend of established hardware incumbents, fast-growing software specialists, and an expanding ecosystem of services providers. Established equipment manufacturers continue to invest in platform modernization and field service expansion to protect installed bases and extend service-driven revenue. At the same time, software-first entrants and AI specialists push the agenda on clinical decision support, image enhancement, and workflow automation, prompting legacy vendors to pursue partnerships, acquisitions, or in-house analytics development to remain competitive.

Strategic alliances between imaging manufacturers and cloud providers or analytics firms are becoming more common as vendors seek to offer integrated solutions rather than standalone devices. These collaborations prioritize joint go-to-market strategies that bundle hardware with subscription-based software and managed services, aligning incentives around uptime, outcomes, and continuous product improvement. Additionally, companies that build robust training and remote support capabilities differentiate through higher clinician adoption and lower total cost of ownership over the equipment lifecycle.

Mergers and targeted investments continue to reshape the vendor landscape, but differentiation increasingly rests on the ability to demonstrate clinical impact, regulatory compliance, and scalable deployment models. Organizations that excel in field service, data security, and interoperability are more successful at converting pilot projects into enterprise-wide deployments. New entrants that focus on modularity, affordability, and user-centered design find opportunities in outpatient centers and emerging markets, while premium offerings concentrate on high-acuity hospital systems and research facilities.

Actionable, phased strategies to strengthen supply resilience, monetize software and services, and align evidence generation with payer and regulatory expectations

Industry leaders should pursue a set of pragmatic, sequenced actions to navigate turbulence and capture upside from ongoing technological shifts. First, prioritize supply chain resilience by diversifying supplier bases, qualifying alternate component sources, and incorporating flexible contract terms that account for trade policy volatility. This will reduce delivery risk and protect operational continuity for clinical customers.

Second, accelerate software integration and modular design to enable incremental upgrades and subscription-based revenue streams. Organizations that separate hardware lifecycles from software innovation can offer continuous clinical improvements without forcing premature hardware replacement. Third, invest in services and workforce development: scaled installation, preventive maintenance, and clinician training programs increase adoption rates and protect brand reputation. These investments also create recurring revenue and strengthen customer relationships.

Fourth, align product development and evidence generation with payer and regulator expectations by supporting real-world evidence studies, health economic analyses, and interoperability standards. Demonstrating measurable improvements in diagnostic accuracy, time-to-treatment, or workflow efficiency will ease procurement and reimbursement hurdles. Fifth, pursue targeted regional strategies: localize pricing, financing, and service models to reflect regional payer structures and operational realities. Finally, embrace sustainability and lifecycle planning to reduce energy consumption, extend equipment longevity, and respond to institutional ESG commitments. Taken together, these actions create a resilient commercial model that balances innovation with operational reliability.

A rigorous, multi-method research approach combining primary stakeholder interviews, technical validation, and scenario analysis to generate decision-ready insights

This research synthesis relies on a blended methodology that emphasizes triangulation of primary stakeholder input, technical documentation, and observational analysis to ensure robustness and practical relevance. Primary research included structured interviews with clinical leaders, procurement officers, field engineers, and technology executives to capture firsthand perspectives on modality-specific performance, service challenges, and adoption barriers. These qualitative insights were supplemented with technical white papers, regulatory filings, and product literature to validate device capabilities and compliance trajectories.

Analytical approaches incorporated comparative feature mapping across modality types, component lifecycles, and software ecosystems, enabling consistent cross-sectional analysis. Scenario-based evaluation was applied to assess the operational implications of supply chain disruptions, policy shifts, and technology diffusion, while expert panels provided validation of synthesized findings to minimize interpretative bias. Throughout the process, data quality controls included source triangulation, version control for technical specifications, and sensitivity checks for qualitative assertions.

Limitations are acknowledged: proprietary sales data and institution-level procurement contracts were not accessible for confidentiality reasons, and regional heterogeneity means that some operational recommendations should be tailored locally. Nevertheless, the methodology emphasizes transparency, reproducibility, and practical applicability, providing decision-ready insight grounded in current clinical practice and vendor strategies.

A concise synthesis of pivotal priorities that unify technological innovation, clinical outcomes, and resilient operations to secure long-term value in diagnostic imaging

The diagnostic imaging sector stands at an inflection point where technological innovation, service delivery models, and policy environments converge to redefine what clinical imaging can deliver. Strategic choices made today around supply chain architecture, software integration, and service capabilities will determine which organizations capture clinical value and sustain competitive differentiation. Stakeholders that adopt a systems perspective-balancing hardware performance, software-enabled workflows, workforce readiness, and financing mechanisms-will be best positioned to translate innovation into routine clinical benefit.

The most successful pathways emphasize modularity, evidence-backed value propositions, and resilient operational models that can withstand policy and supply shocks. By focusing on interoperability, clinician adoption, and demonstrable improvements in diagnostic outcomes and throughput, providers and vendors can align incentives across the care continuum and enable more predictable procurement cycles. Ultimately, the sector's near-term priorities involve converting pilot-scale innovations into scalable, secure, and clinician-centric solutions that support patient access and institutional objectives.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Integration of artificial intelligence algorithms in imaging workflows to enhance diagnostic accuracy and efficiency
  • 5.2. Expansion of portable and point-of-care ultrasound devices for decentralized imaging in remote and ambulatory settings
  • 5.3. Adoption of cloud-based PACS and image sharing platforms to facilitate tele-radiology and collaborative diagnostics
  • 5.4. Development of ultra-high resolution imaging modalities for early detection of microvascular and structural anomalies
  • 5.5. Implementation of radiation dose reduction technologies in CT and X-ray systems to improve patient safety

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Diagnostic Imaging Market, by Modality

  • 8.1. Computed Tomography
    • 8.1.1. Cone Beam Computed Tomography
    • 8.1.2. Conventional Computed Tomography
    • 8.1.3. Portable Computed Tomography
  • 8.2. Magnetic Resonance Imaging
    • 8.2.1. High-Field Magnetic Resonance Imaging
    • 8.2.2. Low-Field Magnetic Resonance Imaging
    • 8.2.3. Ultra-High-Field Magnetic Resonance Imaging
  • 8.3. Nuclear Medicine
    • 8.3.1. Positron Emission Tomography
    • 8.3.2. Single Photon Emission Computed Tomography
  • 8.4. Ultrasound
    • 8.4.1. 2D Ultrasound
    • 8.4.2. 3D Ultrasound
    • 8.4.3. 4D Ultrasound
    • 8.4.4. Doppler Ultrasound
  • 8.5. X-Ray
    • 8.5.1. Computed Radiography
    • 8.5.2. Digital Radiography

9. Diagnostic Imaging Market, by Component

  • 9.1. Hardware
    • 9.1.1. Coils
    • 9.1.2. Detectors
    • 9.1.3. Generators
    • 9.1.4. Transducers
  • 9.2. Services
    • 9.2.1. Consulting
    • 9.2.2. Installation
    • 9.2.3. Maintenance
    • 9.2.4. Training
  • 9.3. Software
    • 9.3.1. AI Analytics
    • 9.3.2. PACS
    • 9.3.3. Reporting Software
    • 9.3.4. RIS

10. Diagnostic Imaging Market, by End User

  • 10.1. Clinics
  • 10.2. Diagnostic Centers
  • 10.3. Hospitals
  • 10.4. Research Institutes

11. Diagnostic Imaging Market, by Application

  • 11.1. Cardiology
  • 11.2. Dental
  • 11.3. Neurology
  • 11.4. Obstetrics/Gynecology
  • 11.5. Oncology
  • 11.6. Ophthalmology
  • 11.7. Orthopedics

12. Diagnostic Imaging Market, by Technology Type

  • 12.1. 2D Imaging
  • 12.2. 3D Imaging
  • 12.3. 4D Imaging

13. Diagnostic Imaging Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Diagnostic Imaging Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Diagnostic Imaging Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. GE HealthCare Technologies, Inc.
    • 16.3.2. Siemens Healthineers AG
    • 16.3.3. Koninklijke Philips N.V.
    • 16.3.4. Canon Medical Systems Corporation
    • 16.3.5. Fujifilm Holdings Corporation
    • 16.3.6. Samsung Medison Co., Ltd.
    • 16.3.7. Mindray Medical International Limited
    • 16.3.8. Shimadzu Corporation
    • 16.3.9. Hitachi, Ltd.
    • 16.3.10. Hologic, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY MODALITY, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY MODALITY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY COMPONENT, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY COMPONENT, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY TECHNOLOGY TYPE, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY TECHNOLOGY TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS DIAGNOSTIC IMAGING MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA DIAGNOSTIC IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA DIAGNOSTIC IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA DIAGNOSTIC IMAGING MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE DIAGNOSTIC IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST DIAGNOSTIC IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA DIAGNOSTIC IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC DIAGNOSTIC IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN DIAGNOSTIC IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC DIAGNOSTIC IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION DIAGNOSTIC IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS DIAGNOSTIC IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 DIAGNOSTIC IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO DIAGNOSTIC IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. DIAGNOSTIC IMAGING MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. DIAGNOSTIC IMAGING MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. DIAGNOSTIC IMAGING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY MODALITY, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY CONE BEAM COMPUTED TOMOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY CONE BEAM COMPUTED TOMOGRAPHY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY CONE BEAM COMPUTED TOMOGRAPHY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY CONE BEAM COMPUTED TOMOGRAPHY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY CONE BEAM COMPUTED TOMOGRAPHY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY CONE BEAM COMPUTED TOMOGRAPHY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY CONVENTIONAL COMPUTED TOMOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY CONVENTIONAL COMPUTED TOMOGRAPHY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY CONVENTIONAL COMPUTED TOMOGRAPHY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY CONVENTIONAL COMPUTED TOMOGRAPHY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY CONVENTIONAL COMPUTED TOMOGRAPHY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY CONVENTIONAL COMPUTED TOMOGRAPHY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY PORTABLE COMPUTED TOMOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY PORTABLE COMPUTED TOMOGRAPHY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY PORTABLE COMPUTED TOMOGRAPHY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY PORTABLE COMPUTED TOMOGRAPHY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY PORTABLE COMPUTED TOMOGRAPHY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY PORTABLE COMPUTED TOMOGRAPHY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY HIGH-FIELD MAGNETIC RESONANCE IMAGING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY HIGH-FIELD MAGNETIC RESONANCE IMAGING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY HIGH-FIELD MAGNETIC RESONANCE IMAGING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY HIGH-FIELD MAGNETIC RESONANCE IMAGING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY HIGH-FIELD MAGNETIC RESONANCE IMAGING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY HIGH-FIELD MAGNETIC RESONANCE IMAGING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY LOW-FIELD MAGNETIC RESONANCE IMAGING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY LOW-FIELD MAGNETIC RESONANCE IMAGING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY LOW-FIELD MAGNETIC RESONANCE IMAGING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY LOW-FIELD MAGNETIC RESONANCE IMAGING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY LOW-FIELD MAGNETIC RESONANCE IMAGING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY LOW-FIELD MAGNETIC RESONANCE IMAGING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY ULTRA-HIGH-FIELD MAGNETIC RESONANCE IMAGING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY ULTRA-HIGH-FIELD MAGNETIC RESONANCE IMAGING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY ULTRA-HIGH-FIELD MAGNETIC RESONANCE IMAGING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY ULTRA-HIGH-FIELD MAGNETIC RESONANCE IMAGING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY ULTRA-HIGH-FIELD MAGNETIC RESONANCE IMAGING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY ULTRA-HIGH-FIELD MAGNETIC RESONANCE IMAGING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY NUCLEAR MEDICINE, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY NUCLEAR MEDICINE, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY NUCLEAR MEDICINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY NUCLEAR MEDICINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY NUCLEAR MEDICINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY NUCLEAR MEDICINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY NUCLEAR MEDICINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY NUCLEAR MEDICINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY ULTRASOUND, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY ULTRASOUND, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY ULTRASOUND, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY ULTRASOUND, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY ULTRASOUND, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY ULTRASOUND, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY ULTRASOUND, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY ULTRASOUND, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY 2D ULTRASOUND, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY 2D ULTRASOUND, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY 2D ULTRASOUND, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY 2D ULTRASOUND, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY 2D ULTRASOUND, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY 2D ULTRASOUND, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY 3D ULTRASOUND, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY 3D ULTRASOUND, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY 3D ULTRASOUND, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY 3D ULTRASOUND, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY 3D ULTRASOUND, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY 3D ULTRASOUND, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY 4D ULTRASOUND, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY 4D ULTRASOUND, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY 4D ULTRASOUND, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY 4D ULTRASOUND, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY 4D ULTRASOUND, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY 4D ULTRASOUND, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY DOPPLER ULTRASOUND, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY DOPPLER ULTRASOUND, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY DOPPLER ULTRASOUND, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY DOPPLER ULTRASOUND, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY DOPPLER ULTRASOUND, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY DOPPLER ULTRASOUND, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY X-RAY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY X-RAY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY X-RAY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY X-RAY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY X-RAY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY X-RAY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY X-RAY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY X-RAY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY COMPUTED RADIOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY COMPUTED RADIOGRAPHY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY COMPUTED RADIOGRAPHY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY COMPUTED RADIOGRAPHY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY COMPUTED RADIOGRAPHY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY COMPUTED RADIOGRAPHY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY DIGITAL RADIOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY DIGITAL RADIOGRAPHY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY DIGITAL RADIOGRAPHY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY DIGITAL RADIOGRAPHY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY DIGITAL RADIOGRAPHY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY DIGITAL RADIOGRAPHY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY COMPONENT, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY HARDWARE, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY HARDWARE, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY HARDWARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY HARDWARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY HARDWARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY HARDWARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY HARDWARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY HARDWARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY COILS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY COILS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY COILS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY COILS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY COILS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY COILS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY DETECTORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY DETECTORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY DETECTORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY DETECTORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY DETECTORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY DETECTORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY GENERATORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY GENERATORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY GENERATORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY GENERATORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY GENERATORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY GENERATORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY TRANSDUCERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY TRANSDUCERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY TRANSDUCERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY TRANSDUCERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY TRANSDUCERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY TRANSDUCERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY SERVICES, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY SERVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY SERVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY SERVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY SERVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY SERVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY SERVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY CONSULTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY CONSULTING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY CONSULTING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY CONSULTING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY CONSULTING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY CONSULTING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY INSTALLATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY INSTALLATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY INSTALLATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY INSTALLATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY INSTALLATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY INSTALLATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY MAINTENANCE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY MAINTENANCE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY MAINTENANCE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY MAINTENANCE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY MAINTENANCE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY MAINTENANCE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY TRAINING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY TRAINING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY TRAINING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY TRAINING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY TRAINING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY TRAINING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY SOFTWARE, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY SOFTWARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY SOFTWARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY SOFTWARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY AI ANALYTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY AI ANALYTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY AI ANALYTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY AI ANALYTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY AI ANALYTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY AI ANALYTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY PACS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY PACS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY PACS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY PACS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY PACS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY PACS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY REPORTING SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY REPORTING SOFTWARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY REPORTING SOFTWARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY REPORTING SOFTWARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY REPORTING SOFTWARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY REPORTING SOFTWARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY RIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY RIS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY RIS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY RIS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY RIS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY RIS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 235. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 237. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 238. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 239. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 240. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 241. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 242. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 243. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 244. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 245. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 246. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 247. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 248. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 249. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 250. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 251. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 252. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 253. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 254. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 255. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 256. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 257. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 258. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY CARDIOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 259. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY CARDIOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 260. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY CARDIOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 261. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY CARDIOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 262. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY CARDIOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 263. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY DENTAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 264. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY DENTAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 265. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY DENTAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 266. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY DENTAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 267. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY DENTAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 268. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY DENTAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 269. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 270. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY NEUROLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 271. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY NEUROLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 272. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY NEUROLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 273. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY NEUROLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 274. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY NEUROLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 275. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY OBSTETRICS/GYNECOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 276. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY OBSTETRICS/GYNECOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 277. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY OBSTETRICS/GYNECOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 278. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY OBSTETRICS/GYNECOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 279. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY OBSTETRICS/GYNECOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 280. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY OBSTETRICS/GYNECOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 281. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 282. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 283. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 284. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY ONCOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 285. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 286. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 287. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY OPHTHALMOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 288. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY OPHTHALMOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 289. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY OPHTHALMOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 290. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY OPHTHALMOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 291. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY OPHTHALMOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 292. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY OPHTHALMOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 293. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY ORTHOPEDICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 294. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY ORTHOPEDICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 295. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY ORTHOPEDICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 296. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY ORTHOPEDICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 297. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY ORTHOPEDICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 298. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY ORTHOPEDICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 299. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
  • TABLE 300. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2032 (USD MILLION)
  • TABLE 301. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY 2D IMAGING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 302. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY 2D IMAGING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 303. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY 2D IMAGING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 304. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY 2D IMAGING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 305. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY 2D IMAGING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 306. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY 2D IMAGING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 307. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY 3D IMAGING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 308. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY 3D IMAGING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 309. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY 3D IMAGING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 310. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY 3D IMAGING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 311. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY 3D IMAGING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 312. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY 3D IMAGING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 313. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY 4D IMAGING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 314. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY 4D IMAGING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 315. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY 4D IMAGING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 316. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY 4D IMAGING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 317. GLOBAL DIAGNOSTIC IMAGING MARKET SIZE, BY 4D IMAGING